Biogen Idec Inc. (BIIB) reported second quarter non-GAAP EPS of $3.49 Wednesday morning, up from $2.30 last year. Analysts expected EPS of $2.83. The company now expects to report full year non-GAAP EPS of $12.90 to $13.10, up from prior guidance of $11.35 to $11.45. The consensus estimate is for EPS of $11.53.
Biogen Idec gapped open sharply higher this morning and is now up 37.09 at $340.76 on above average volume. The stock has broken out of a 2-month range and has set a 4-month high.
For comments and feedback contact: editorial@rttnews.com
Business News